OS and EFS survival by disease status and peripheral blood blasts. Patients with active disease at HSCT were divided into 2 subgroups according to the presence or absence of circulating blasts. The outcome of patients with refractory disease without circulating blasts was significantly better than that of patients with peripheral blood disease. PB indicates peripheral blood.